Literature DB >> 8181852

Homozygous deletion, rearrangement and hypermethylation implicate chromosome region 3p14.3-3p21.3 in sporadic breast-cancer development.

D L Buchhagen1, L Qiu, P Etkind.   

Abstract

DNAs from 19 malignant human breast tumors and 2 benign fibroadenomas were analyzed for heterozygosity at 5 polymorphic loci on the short arm of chromosome 3. One homozygous deletion and one rearrangement were identified using probe D3S2 which maps to 3p14.3-3p21.1. This probe also detected novel hybridizing fragments of 2.0 kb and/or 3.4 kb in 6/18 (33%) of the malignant tumor samples that hybridized with the D3S2 probe following digestion with the 5'-methylcytosine-insensitive enzyme MspI. Comparisons of HpaII and MspI digestion showed that all but one of the tumor DNAs analyzed were hypermethylated. The two fibroadenoma DNAs were not as highly methylated and had hybridizing fragments of 3.4 kb after HpaII digestion. These malignant breast-tumor DNAs exhibit 3 mechanisms by which a tumor-suppressor gene hypothesized to reside at 3p14-3p21 could be inactivated: homozygous deletion, rearrangement and hypermethylation, and strongly implicate this 3p chromosome region in breast-tumor development.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8181852     DOI: 10.1002/ijc.2910570406

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  18 in total

1.  Germline BAP1 mutations and tumor susceptibility.

Authors:  Alisa M Goldstein
Journal:  Nat Genet       Date:  2011-09-28       Impact factor: 38.330

2.  High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss.

Authors:  A Maitra; I I Wistuba; C Washington; A K Virmani; R Ashfaq; S Milchgrub; A F Gazdar; J D Minna
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

3.  BAP1 and breast cancer risk.

Authors:  Isabelle Coupier; Pierre-Yves Cousin; David Hughes; Patricia Legoix-Né; Alexandra Trehin; Olga M Sinilnikova; Dominique Stoppa-Lyonnet
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

4.  Cytogenetic studies on a patient with prepubertal breast cancer: a case report.

Authors:  B R Balsara; T Varughese; A V Bhat; R S Rao; A N Bhisey
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

5.  Dissenting degradation: Deubiquitinases in cell cycle and cancer.

Authors:  Thomas Bonacci; Michael J Emanuele
Journal:  Semin Cancer Biol       Date:  2020-03-20       Impact factor: 15.707

6.  Cytogenetic abnormalities in an in situ ductal carcinoma and five prophylactically removed breasts from members of a family with hereditary breast cancer.

Authors:  M R Teixeira; N Pandis; A M Gerdes; C U Dietrich; G Bardi; J A Andersen; H P Graversen; F Mitelman; S Heim
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

7.  Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1.

Authors:  Shahram Misaghi; Søren Ottosen; Anita Izrael-Tomasevic; David Arnott; Mohamed Lamkanfi; James Lee; Jinfeng Liu; Karen O'Rourke; Vishva M Dixit; Angus C Wilson
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

8.  The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1.

Authors:  Yuichi J Machida; Yuka Machida; Ajay A Vashisht; James A Wohlschlegel; Anindya Dutta
Journal:  J Biol Chem       Date:  2009-10-08       Impact factor: 5.157

9.  BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization.

Authors:  Karen H Ventii; Narra S Devi; Kenneth L Friedrich; Tatiana A Chernova; Mourad Tighiouart; Erwin G Van Meir; Keith D Wilkinson
Journal:  Cancer Res       Date:  2008-09-01       Impact factor: 12.701

10.  HIGD1A Regulates Oxygen Consumption, ROS Production, and AMPK Activity during Glucose Deprivation to Modulate Cell Survival and Tumor Growth.

Authors:  Kurosh Ameri; Arman Jahangiri; Anthony M Rajah; Kathryn V Tormos; Ravi Nagarajan; Melike Pekmezci; Vien Nguyen; Matthew L Wheeler; Michael P Murphy; Timothy A Sanders; Stefanie S Jeffrey; Yerem Yeghiazarians; Paolo F Rinaudo; Joseph F Costello; Manish K Aghi; Emin Maltepe
Journal:  Cell Rep       Date:  2015-02-13       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.